Literature DB >> 18618193

Large apical thrombus in a patient with persistent heart failure and hypereosinophilia: Löffler endocarditis.

A Altug Cincin1, Beste Ozben, M Azra Tanrikulu, Ozdil Baskan, Mehmet Agirbasli.   

Abstract

Idiopathic hypereosinophilic syndrome is an uncommon leukoproliferative systemic disorder characterized by the overproduction of eosinophils and poor prognosis. A major source of morbidity and mortality of this syndrome is the associated cardiac involvement represented by endocardial thickening and mural thrombi. We report a 64-year-old woman with persistent symptoms of heart failure despite standard medical therapy. Echocardiography revealed reduced left ventricular filling due to a large apical mass; an abnormal diastolic filling pattern was also noticed. Complete blood count revealed remarkable hypereosinophilia. Cardiac magnetic resonance imaging demonstrated an apical thrombus and intense linear enhancement of the endocardium, which were compatible with Löffler endocarditis. Medical therapy, including corticosteroids and anticoagulation, was initiated promptly. The symptoms improved as the peripheral hypereosinophilia resolved in 15 days. The patient was asymptomatic at the 1-year follow-up visit with complete regression of the apical thrombus and no evidence of restrictive cardiomyopathy. We report this case to draw attention to this particularly rare condition with poor prognosis since quick and accurate diagnosis and prompt initiation of therapy may improve symptoms and survival.

Entities:  

Mesh:

Year:  2008        PMID: 18618193      PMCID: PMC2533383          DOI: 10.1007/s11606-008-0705-y

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN: 0884-8734            Impact factor:   5.128


  34 in total

Review 1.  Role of cardiac magnetic resonance imaging in the assessment of myocardial viability.

Authors:  Kesavan Shan; Godwin Constantine; Mohan Sivananthan; Scott D Flamm
Journal:  Circulation       Date:  2004-03-23       Impact factor: 29.690

Review 2.  Restrictive cardiomyopathy.

Authors:  S S Kushwaha; J T Fallon; V Fuster
Journal:  N Engl J Med       Date:  1997-01-23       Impact factor: 91.245

3.  Idiopathic hypereosinophilic syndrome in a 5 1/2-month-old infant.

Authors:  S R Wynn; M I Sachs; M U Keating; N K Ostrom; R P Kadota; E J O'Connell; W A Smithson
Journal:  J Pediatr       Date:  1987-07       Impact factor: 4.406

Review 4.  [Prognostic factors of hypereosinophilic syndrome. Study of 40 cases].

Authors:  C Lefebvre; O Bletry; P Degoulet; L Guillevin; M Bentata-Pessayre; D u Le Thi Huong; P Godeau
Journal:  Ann Med Interne (Paris)       Date:  1989

5.  Case report: rapid and complete control of idiopathic hypereosinophilia with imatinib mesylate.

Authors:  J L Schaller; G A Burkland
Journal:  MedGenMed       Date:  2001-09-07

6.  Surgery for endomyocardial fibrosis revisited.

Authors:  F Moraes; C Lapa; S Hazin; E Tenorio; C Gomes; C R Moraes
Journal:  Eur J Cardiothorac Surg       Date:  1999-03       Impact factor: 4.191

7.  Steroid-refractory neonatal eosinophilic pneumonia responsive to cyclosporin A.

Authors:  R L Morton; L R Shoemaker; N S Eid
Journal:  Am J Respir Crit Care Med       Date:  1999-09       Impact factor: 21.405

8.  Hypereosinophilic syndrome with pulmonary and cardiac involvement in a patient with asthma.

Authors:  Demet Karnak; Oya Kayacan; Sumru Beder; Mustafa Delibalta
Journal:  CMAJ       Date:  2003-01-21       Impact factor: 8.262

9.  The efficacy of imatinib mesylate in patients with FIP1L1-PDGFRalpha-positive hypereosinophilic syndrome. Results of a multicenter prospective study.

Authors:  Michele Baccarani; Daniela Cilloni; Michela Rondoni; Emanuela Ottaviani; Francesca Messa; Serena Merante; Mario Tiribelli; Francesco Buccisano; Nicoletta Testoni; Enrico Gottardi; Antonio de Vivo; Emilia Giugliano; Ilaria Iacobucci; Stefania Paolini; Simona Soverini; Gianantonio Rosti; Francesca Rancati; Cinzia Astolfi; Fabrizio Pane; Giuseppe Saglio; Giovanni Martinelli
Journal:  Haematologica       Date:  2007-08-01       Impact factor: 9.941

10.  Anti-interleukin-5 (mepolizumab) therapy for hypereosinophilic syndromes.

Authors:  Jennifer K Garrett; Sean C Jameson; Blythe Thomson; Margaret H Collins; Lynne E Wagoner; Debbie K Freese; Lisa A Beck; Joshua A Boyce; Alexandra H Filipovich; Joyce M Villanueva; Steven A Sutton; Amal H Assa'ad; Marc E Rothenberg
Journal:  J Allergy Clin Immunol       Date:  2003-12-12       Impact factor: 10.793

View more
  3 in total

1.  Two cases with hypereosinophilic syndrome shown with real-time PCR and responding well to imatinib treatment.

Authors:  Nur Selvi; Burçin Tezcanlı Kaymaz; Handan Haydaroğlu Sahin; Mustafa Pehlivan; Cağdaş Aktan; Ayşegül Dalmızrak; Ezgi Inalpolat; Buket Kosova; Mehmet Yılmaz; Vahap Okan; Güray Saydam
Journal:  Mol Biol Rep       Date:  2012-10-18       Impact factor: 2.316

2.  Löeffler endocarditis and restrictive cardiomyopathy with biventricular apical thrombi.

Authors:  Mitsushige Murata; Risako Yasuda; Hanako Tokuda; Keiko Suzuki; Hikaru Tsuruta; Tatsuya Yamada; Shiro Iwanaga; Akio Kawamura; Makoto Akaishi; Keiichi Fukuda
Journal:  J Echocardiogr       Date:  2013-12-01

3.  Löffler endocarditis: a rare cause of acute cardiac failure.

Authors:  Nicolasine D Niemeijer; Paul L A van Daele; Kadir Caliskan; Frans B S Oei; Olaf J L Loosveld; Nardo J M van der Meer
Journal:  J Cardiothorac Surg       Date:  2012-10-10       Impact factor: 1.637

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.